Scandinavian Cardiovascular Journal ( IF 1.2 ) Pub Date : 2021-08-27 , DOI: 10.1080/14017431.2021.1970802 Rui Shi 1, 2 , Qinghen Wu 3 , Hongtao Tie 3
Abstract
Acute kidney injury (AKI) is a common postoperative complication after transcatheter aortic valve replacement (TAVR). In patients with ineligible femoral access, transaxillary/subclavian (TAx/TSc) might be competitive alternative access. With nine cohort studies and 4995 patients, we found that TAx/TSc access was associated with decreased incidences of AKI (Relative risk [RR]: 0.573, 95% confidence interval [CI]:0.456−0.718, p < .001) and stage 3 AKI (RR 0.460, 95%CI 0.318−0.665, p < .001) by comparison with intrathoracic approaches. Our findings suggest that TAx/TSc is associated with a reduced AKI risk after TAVR in patients with impossible femoral access.
中文翻译:
经导管主动脉瓣植入术患者经腋/锁骨下通路的肾脏保护
摘要
急性肾损伤(AKI)是经导管主动脉瓣置换术(TAVR)后常见的术后并发症。对于不符合股骨通路的患者,经腋窝/锁骨下通路 (TAx/TSc) 可能是有竞争力的替代通路。通过 9 项队列研究和 4995 名患者,我们发现 TAx/TSc 通路与 AKI 发生率降低相关(相对风险 [RR]:0.573,95% 置信区间 [CI]:0.456-0.718,p < .001)和分期3 AKI(RR 0.460,95%CI 0.318-0.665,p < .001)与胸腔内入路比较。我们的研究结果表明,对于无法进入股骨的患者,TAx/TSc 与 TAVR 后 AKI 风险降低相关。